• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1550225-28
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Stenosis (2263); No Code Available (3191)
Date of Event 11/18/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of stenosis is listed in the xience sierra, everolimus eluting coronary stent system (eecss), electronic instructions for use (ifu) as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Event or Problem Description
It was reported that on (b)(6) 2019 the patient presented with unstable angina therefore the 2.25x28mm and 2.50x33mm xience sierra stents were implanted.On (b)(6) 2019 the patient was re-admitted with atherosclerotic heart disease and other cardiovascular symptoms.It is unknown what treatment was performed and the final patient outcome is unknown.No additional information was provided.
 
Additional Manufacturer Narrative
Patient code 2263 was removed.Conclusion code 22 was removed.
 
Event or Problem Description
It was reported that on (b)(6) 2019 the patient presented with unstable angina therefore the 2.25x28mm and 2.50x33mm xience sierra stents were implanted.On (b)(6) 2019 the patient was re-admitted with atherosclerotic heart disease and other cardiovascular symptoms.It is unknown what treatment was performed and the final patient outcome is unknown.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9788173
Report Number2024168-2020-02009
Device Sequence Number19299254
Product Code NIQ
UDI-Device Identifier08717648227042
UDI-Public08717648227042
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source health professional,other,use
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/19/2020
Device Model Number1550225-28
Device Catalogue Number1550225-28
Device Lot Number9021341
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 02/14/2020
Supplement Date Received by Manufacturer03/05/2020
Initial Report FDA Received Date03/04/2020
Supplement Report FDA Received Date03/20/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
2.50X33 XIENCE SIERRA.
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age48 YR
Patient Weight118
-
-